SS

Sharad Srivastav

Director Director DIN 10054673
DIN 10054673 First appointment Feb 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2023
Shareholding value Locked Premium profile

About Sharad Srivastav

Data last updated:

Sharad Srivastav has 3 years in corporate governance. Formerly with 1 company, such as Jeevandan Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10054673
Primary Designation Director
First Appointment 28 Feb 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director28 Feb 20232022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jeevandan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sharad Srivastav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharad Srivastav

Sharad Srivastav has 3 years in corporate governance. Formerly with 1 company, such as Jeevandan Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sharad Srivastav is associated with 0 companies as a director.

Sharad Srivastav has expertise in General Business.

Sharad Srivastav has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available